CLASS II Device recall · Reported 22 Sep 2021 · FDA Enforcement Report

cobas infinity central lab running recalled

Roche Diagnostics Operations is recalling cobas infinity central lab running, distributed nationwide in the US. The recall was initiated on 24 Jun 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 04015630936007; All systems running software version 3.01.03 - 3.02.08
Quantity recalled2058 licenses worldwide, 79 licenses in US

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2444-2021
FDA event ID
88398
Recalling firm
Roche Diagnostics Operations, Indianapolis, IN
Classification
Class II
Status
Terminated
Recall initiated
24 Jun 2021
FDA classified
10 Sep 2021
Reported
22 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

24 Jun 2021Recall initiated by company
10 Sep 2021Classified by FDA+78 days
22 Sep 2021Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by your Laboratory Information System (LIS) as a false positive or negative result. It should be noted that the "correct" result would still be available on the instrument.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

cobas infinity central lab running software version 3.01.03 through 3.02.08, Catalog#: 07154003001

Where it was distributed

US Nationwide distribution

Nationwide

Questions about this recall

Is cobas infinity central lab running recalled?

Yes. Roche Diagnostics Operations recalled cobas infinity central lab running on 24 Jun 2021. The recall is Class II and its status is Terminated. Recall number Z-2444-2021.

Why was it recalled?

Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by your Laboratory Information System (LIS) as a false positive or negative result. It should be noted that the "correct" result would still be available on the instrument.

Which lots are affected?

UDI: 04015630936007; All systems running software version 3.01.03 - 3.02.08

Where was it sold?

US Nationwide distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Diagnostics Operations

All 127

Other Medical Software recalls

All 903